Literature DB >> 19351692

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Miguel Blanco1, Maria Pilar Alonso, Marie-Hélène Nicolas-Chanoine, Ghizlane Dahbi, Azucena Mora, Jesús E Blanco, Cecilia López, Pilar Cortés, Montserrat Llagostera, Véronique Leflon-Guibout, Beatriz Puentes, Rosalía Mamani, Alexandra Herrera, María Amparo Coira, Fernando García-Garrote, Julia María Pita, Jorge Blanco.   

Abstract

OBJECTIVES: Having shown that the Xeral-Calde Hospital in Lugo (Spain) has been concerned by Escherichia coli clone O25:H4-ST131 producing CTX-M-15 (Nicolas-Chanoine et al. J Antimicrob Chemother 2008; 61: 273-81), the present study was carried out to evaluate the prevalence of this clone among the extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates and also to molecularly characterize the E. coli isolates producing ESBL other than CTX-M-15.
METHODS: In the first part of this study, 105 ESBL-producing E. coli isolates (February 2006 to March 2007) were characterized with regard to ESBL enzymes, serotypes, virulence genes, phylogenetic groups, multilocus sequence typing (MLST) and PFGE. In the second part of this study, 249 ESBL-producing E. coli isolates (April 2007 to May 2008) were investigated only for the detection of clone O25b:H4-ST131 producing CTX-M-15 using a triplex PCR developed in this study and based on the detection of the new operon afa FM955459 and the targets rfbO25b and 3' end of the bla(CTX-M-15) gene.
RESULTS: Of the 105 ESBL-producing E. coli isolates, 60 (57.1%) were positive for CTX-M-14, 23 (21.9%) for CTX-M-15, 10 (9.5%) for SHV-12 and 7 (6.7%) for CTX-M-32. Serotypes, virulence genes, phylogenetic groups and molecular typing by PFGE demonstrated high homogeneity within those producing CTX-M-15 and high diversity within E. coli producing CTX-M-14 and other ESBLs. By PFGE, CTX-M-15-producing E. coli isolates O25b:H4 belonging to the phylogenetic group B2 and MLST profile ST131 were grouped in the same cluster. The epidemic strain of clone O25b:H4-ST131 represented 23.1%, 22.5% and 20.0% of all ESBL-producing E. coli isolated in 2006, 2007 and 2008, respectively.
CONCLUSIONS: CTX-M-type ESBLs, primarily CTX-M-14 and CTX-M-15, have emerged as the predominant types of ESBL produced by E. coli isolates in Lugo. In view of the reported findings, long-term care facilities for elderly people may represent a significant reservoir for E. coli clone O25b:H4-ST131 producing CTX-M-15. The triplex PCR developed in this work will be useful for rapid and simple detection of this clone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351692     DOI: 10.1093/jac/dkp122

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  49 in total

1.  Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features.

Authors:  C Ruiz de Alegría; J Rodríguez-Baño; M E Cano; J R Hernández-Bello; J Calvo; E Román; M A Díaz; A Pascual; L Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

2.  Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia.

Authors:  R Ben Sallem; K Ben Slama; V Estepa; A Jouini; H Gharsa; N Klibi; Y Sáenz; F Ruiz-Larrea; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-08       Impact factor: 3.267

3.  Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels.

Authors:  James H Jorgensen; M L McElmeel; L C Fulcher; B L Zimmer
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

Review 4.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.

Authors:  Oihane Martín; Aránzazu Valverde; María I Morosini; Mario Rodríguez-Domínguez; Mercedes Rodríguez-Baños; Teresa M Coque; Rafael Cantón; Rosa del Campo
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

6.  Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.

Authors:  Sherief El-Shazly; Ali Dashti; Leila Vali; Michael Bolaris; Ashraf S Ibrahim
Journal:  Int J Infect Dis       Date:  2015-10-27       Impact factor: 3.623

7.  Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.

Authors:  Azucena Mora; Alexandra Herrera; Rosalia Mamani; Cecilia López; María Pilar Alonso; Jesús E Blanco; Miguel Blanco; Ghizlane Dahbi; Fernando García-Garrote; Julia María Pita; Amparo Coira; María Isabel Bernárdez; Jorge Blanco
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

8.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.

Authors:  A Boutet-Dubois; A Pantel; M-F Prère; O Bellon; N Brieu-Roche; E Lecaillon; A Le Coustumier; A Davin-Regli; L Villeneuve; N Bouziges; E Gleize; R Lamarca; C Dunyach-Remy; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-15       Impact factor: 3.267

10.  Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Johann Dd Pitout
Journal:  F1000 Med Rep       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.